Core Viewpoint - JinkoSolar plans to release its unaudited financial results for the second and third quarters of 2025 on November 17, 2025, before U.S. market opening [1]. Group 1: Financial Results Announcement - The unaudited financial results for Q2 and Q3 2025 will be announced before the market opens on November 17, 2025 [1]. - An earnings conference call is scheduled for the same day at 7:30 a.m. U.S. Eastern Time [2]. - Participants must register in advance to receive dial-in numbers and access information [2][3]. Group 2: Company Overview - JinkoSolar is one of the largest and most innovative solar module manufacturers globally, distributing products to a diverse international customer base [4]. - The company operates over 10 production facilities and has more than 20 overseas subsidiaries in various countries, including Japan, South Korea, and the United States [5].

Core Insights - Public perceptions of cancer care in the Philippines reveal significant gaps in the continuum from screening to survivorship, highlighting the need for improved awareness and access to services [1][2][4] Screening and Diagnosis - A survey of over 6,000 individuals across six Southeast Asian countries indicates a strong belief in the importance of early detection, with 76% acknowledging its benefits, yet only 13% of respondents in the Philippines have undergone cancer screening, the second lowest in the region [2][4][7] - Among those screened, only 4% had specific cancer screening tests, and nearly 45% had never considered screening, significantly higher than the regional average of 33% [4][6] Treatment Awareness and Access - Knowledge of modern cancer therapies is limited, with 80% recognizing chemotherapy and 58% surgery, but only 30% are aware of radiotherapy and just 10% of newer therapies like precision and immunotherapy [7][8] - Only 29% view treatment as accessible, and 62% consider it unaffordable, the second highest concern in Southeast Asia after Singapore [8] Survivorship and Post-Treatment Care - While 83% are aware of post-treatment care, over half (57%) do not understand what it entails, indicating a significant gap in knowledge [9] - There is a strong expectation for easy access to diagnostic tests (65%) and regular follow-up care (64%) post-treatment [9][10] Confidence in Care Coordination - Confidence in coordinated cancer care is low, with only 34% believing it is well-coordinated and 36% feeling confident in a 'one-stop' care model, among the lowest in Southeast Asia [11] - There is optimism regarding digital innovation, with 41% open to using artificial intelligence in cancer care, provided it is clinician-led and transparent [12][13] Opportunities for Improvement - The findings suggest opportunities for enhancing patient pathways through more coordinated care, affordable access, and the integration of digital tools that support healthcare professionals [13][14] - Siemens Healthineers aims to address these gaps by promoting earlier detection, supporting clinicians with digital innovations, and advancing precision treatments [14][19]

Core Viewpoint - JinkoSolar Holding Co., Ltd. has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024, with the SEC, highlighting its position as a leading solar module manufacturer [1]. Company Overview - JinkoSolar is recognized as one of the largest and most innovative solar module manufacturers globally, distributing products and services to a diverse international customer base across multiple countries [3]. - The company operates over 10 production facilities and has more than 20 overseas subsidiaries in various countries, including Japan, South Korea, and the United States, as of March 31, 2025 [4]. Financial Reporting - The annual report on Form 20-F includes audited consolidated financial statements and is accessible on the company's website and the SEC's website [2]. - Shareholders can request a hard copy of the annual report, which contains complete audited financial statements, free of charge [2].